insights_auto
Why is SABS down 3,44%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,81 $
arrow_downward
-3,44%(-0,10) 1D
2,81 $
0,00% (0,00)
bedtimeAfter hours
Closed: 20 қар., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
2,79 $
High
2,88 $
Low
2,64 $
Mkt. cap
253,15 млн
Avg. vol.
709,90 м.
Volume
874,57 м.
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
Open
2,79 $
High
2,88 $
Low
2,64 $
Mkt. cap
253,15 млн
Avg. vol.
709,90 м.
Volume
874,57 м.
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
News stories
From web sources and news partners
The Motley Fool
·
6 сағат бұрын
The S&P 500 Just Whipsawed Near a Record High. Here’s Why I’m Lowering My Expectations, Not Selling.
24/7 Wall St.
·
5 сағат бұрын
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
Yahoo Finance
·
1 күн бұрын
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
WSJ
·
2 күн бұрын
Dow, S&P 500 Poised to Close at a Correction
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Флорида, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitesab.bio